Obesity & Weight Loss

Wegovy Consultation in Seomyeon, Busan

A Wegovy consultation (위고비 상담) is a doctor's assessment to decide whether semaglutide 2.4 mg, a once-weekly GLP-1 injection for chronic weight management, is suitable for you. In Seomyeon, Busan, the visit typically covers BMI, health history, blood tests and contraindications, then injection teaching. The dose is increased gradually over about 16 weeks, and weight loss continues over many months alongside diet and activity changes.

Independent patient guide · Medically informative, not a substitute for a doctor's advice · Last reviewed:

October 2026
Clinic in Seomyeon, Busan

What is Wegovy?

Wegovy is a brand of semaglutide approved for chronic weight management. It mimics GLP-1, a gut hormone that signals fullness to the brain and slows stomach emptying, so people feel satisfied with smaller portions. The same molecule at lower doses is sold as Ozempic for type 2 diabetes. Wegovy is given with a prefilled pen once a week.

Who is it for?

  • Adults with obesity, or overweight with at least one weight-related condition, as defined in the prescribing information
  • People who have tried structured lifestyle changes and need additional support
  • Some adolescents under specialist supervision, depending on local approval

It is not suitable during pregnancy or breastfeeding, and should be stopped some time before planned pregnancy as advised by a doctor. A history of pancreatitis, gallbladder disease, diabetic eye disease or severe gastrointestinal disease needs careful discussion.

What happens at the clinic

  1. Assessment: weight, BMI, waist, blood pressure, medical history and current medications.
  2. Tests: blood sugar or HbA1c, lipids, kidney and liver function as appropriate.
  3. Contraindication check: thyroid cancer history, pancreatitis, pregnancy plans.
  4. Injection training: how to use the pen, where to inject (abdomen, thigh, upper arm) and storage.
  5. Titration plan: dose schedule and follow-up visits roughly every 4 weeks during increases.

Treatment outlook

Appetite usually decreases within weeks, but meaningful weight change builds over months as the dose increases. In clinical trials, average weight loss was substantial over more than a year, though individual responses vary. Many people regain weight after stopping, so the doctor will discuss long-term plans, including diet quality, protein intake and resistance exercise to preserve muscle.

Risks and side effects

  • Gastrointestinal effects: nausea, vomiting, diarrhea, constipation, bloating, especially when increasing doses
  • Gallbladder problems, including gallstones
  • Pancreatitis, rare; seek care for severe persistent abdominal pain
  • Low blood sugar when combined with certain diabetes medicines
  • Dehydration from vomiting or diarrhea, which can affect the kidneys

Choosing a clinic for a Wegovy consultation in Seomyeon

  • Choose a physician who reviews your full health history, not a quick prescription service.
  • Ask how they will manage side effects and when doses will be increased.
  • Ask about nutrition and exercise support to protect muscle mass.
  • Ask about plans if you plan pregnancy or need surgery.
  • Confirm how prescriptions and supplies will be handled if you move or travel.

Travelling with pens

Unopened pens are usually kept refrigerated; follow the label for storage once in use and carry a prescription when flying. Seomyeon's pharmacies are close to its clinics for easy collection.

Key facts

  • Drug: semaglutide 2.4 mg, GLP-1 receptor agonist
  • Dosing: once weekly subcutaneous injection, same day each week
  • Titration: starts low and increases about every 4 weeks to the maintenance dose
  • Eligibility: determined by BMI thresholds and weight-related conditions per prescribing information
  • Common side effects: nausea, vomiting, diarrhea, constipation
  • Not for: pregnancy, personal or family history of medullary thyroid cancer or MEN2
  • Typical NHI coverage: generally paid privately when used for weight management

Frequently asked questions

How much weight can I lose with Wegovy?

Results vary. In clinical trials, many participants lost a substantial percentage of body weight over more than a year when combined with lifestyle changes. Some people respond less. Your doctor will review progress after you reach the maintenance dose.

How long does it take for Wegovy to work?

Appetite often drops within the first few weeks, but the dose is increased gradually over about four months. Most weight loss occurs over the first year of treatment.

Wegovy vs Ozempic: what is the difference?

Both contain semaglutide. Ozempic is approved for type 2 diabetes at lower doses, while Wegovy is approved for weight management at a higher maintenance dose of 2.4 mg weekly.

What happens if I stop Wegovy?

Appetite usually returns and many people regain some weight over the following months. Continuing healthy habits and discussing a maintenance strategy with your doctor helps limit regain.

Can I travel while on Wegovy?

Yes, with planning. Keep pens within the recommended temperature range, carry your prescription and plan injection days around travel. Ask your clinic for storage guidance specific to your pens.

Medical disclaimer: Seomyeon.Clinic is an independent information directory. Content is for general education and does not replace a consultation with a licensed physician. Suitability, risks, results and costs vary by person and clinic. In an emergency in Korea, call 119.